New to Meducation?
Sign up
Already signed up? Log In
view moderators

MacularDegeneration

Category

Preview
0
0

Diet rich in carotenoids is linked to reduced risk of advanced age related macular degeneration

A higher intake of carotenoids, particularly lutein and zeaxanthin, is associated with a long term reduced risk of developing advanced age related macular degeneration (AMD), two large prospective cohort studies published in JAMA Ophthalmology have shown.1  
feeds.bmj.com
about 4 years ago
Preview
0
0

AMD: Continued Anti-VEGF Treatment May Induce Response

Patients who do not initially respond to anti-VEGF treatment for age-related macular degeneration may do so if they continue receiving the same treatment for a longer course of therapy.  
medscape.com
about 4 years ago
Preview
0
5

Carotenoid-Rich Diet May Protect Against Advanced Eye Disease

Dietary components lutein and zeaxanthin reduced the risk for advanced age-related macular degeneration in a large prospective cohort.  
medscape.com
about 4 years ago
Preview
0
0

Laser treatment of drusen to prevent progression to advanced age-related macular degeneration | Cochrane

Review question We reviewed the evidence about the effect of laser treatment of the centre of the retina in people with macular drusen to prevent the occurrence of the more advanced type of age-related macular degeneration (AMD).  
cochrane.org
about 4 years ago
Preview
0
0

Dexamethasone Implants For Macular Edema Due to RVO

Is this a safe and effective therapeutic option for previously untreated patients with macular edema secondary to retinal vein occlusion?  
medscape.com
about 4 years ago
Preview
0
0

Big Data, Combo Drugs, Implants Will Be Focus of AAO 2015

Research from the national IRIS Registry will be presented at the American Academy of Ophthalmology meeting, along with the latest on combination options for macular degeneration and diabetic edema.  
medscape.com
about 4 years ago
Preview
0
8

Squalamine Boosts Anti-VEGF Effect in Macular Degeneration

The addition of squalamine lactate to ranibizumab did not reduce the number of injections in patients with neovascular age-related macular degeneration, but it did improve visual acuity.  
medscape.com
almost 4 years ago
Preview
0
0

Response to Anti-VEGF in Macular Edema Evident at 3 Months

Response to anti-VEGF injections at 3 months is predictive of response at 1 and 3 years, so nonresponders can be switched to a drug with a different mechanism of action early on, researchers report.  
medscape.com
almost 4 years ago
Preview
0
0

Updates in the Management of Geographic Atrophy in Dry Age-Related Macular Degeneration CME

This activity is intended for ophthalmologists, optometrists, and other healthcare professionals who treat patients with AMD.  
medscape.org
almost 4 years ago
Preview
0
0

AMD-Associated Genetic Variants Identified

A large study has identified genetic variants behind the difficult-to-treat 'wet' age-related macular degeneration.  
medscape.com
almost 4 years ago
Preview
0
0

Is Cataract Surgery Safe for Patients With Wet AMD?

Does cataract surgery contribute to the progression of wet age-related macular degeneration?  
medscape.com
almost 4 years ago
Preview
0
0

Anti-VEGF Therapy for Persistent Diabetic Macular Edema

In patients with persistent diabetic macular edema (DME), there may be long-term benefits to be gained from continuing with anti-vascular endothelial growth factor (anti-VEGF) therapy, according to a post hoc analysis of a Diabetic Retinopathy Clinical Research (DRCR) Network trial.  
medscape.com
almost 4 years ago
Preview
0
6

Antiplatelet Drugs May Increase Retinal Bleeding in Wet AMD

A new study has shown a significant association between retinal hemorrhage and anticoagulant or antiplatelet use in patients who have neovascular age-related macular degeneration and hypertension.  
medscape.com
over 3 years ago
Preview
0
0

Survey Shows US AMD Incidence Far Lower Among Blacks

Black people have one tenth the incidence of late age-related macular degeneration compared with white people in the United States, a new survey has shown.  
medscape.com
over 3 years ago
Preview
0
5

Sleep Patterns Linked to Macular Disease

Adults who get more than 8 hours of sleep per night are at increased risk for advanced dry age-related macular degeneration.  
medscape.com
over 3 years ago
Preview
0
5

Atorvastatin: A Drusen Disintegrator?

Can treatment with a high-dose statin for age-related macular degeneration resolve drusen and improve visual acuity?  
medscape.com
over 3 years ago
Preview
0
0

Aflibercept is better drug for diabetic macular oedema, study finds

Three drugs to treat diabetic macular oedema—aflibercept, bevacizumab, and ranibizumab—are equally effective for patients with mild vision loss, a two year trial funded by the US National Institutes of Health shows. However, for patients with moderate or worse vision loss aflibercept produced the greatest gains, the study published in Ophthalmology showed.1  
feeds.bmj.com
over 3 years ago
Preview
0
1

Aflibercept is better drug for diabetic macular oedema, study finds

Three drugs to treat diabetic macular oedema—aflibercept, bevacizumab, and ranibizumab—are equally effective for patients with mild vision loss, a two year trial funded by the US National Institutes of Health shows. However, for patients with moderate or worse vision loss aflibercept produced the greatest gains, the study published in Ophthalmology showed.1  
feeds.bmj.com
over 3 years ago
Preview
0
6

Glaucoma Drops May Help in Refractory AMD

When age-related macular degeneration (AMD) is refractory to intravitreous anti-vascular endothelial growth factor (anti-VEGF), adding dorzolamide-timolol eye drops may be helpful, according to a small pilot study.  
medscape.com
over 3 years ago
Preview
0
0

Aflibercept for Macular Edema Secondary to Central RVO

Aflibercept may be an effective therapeutic option for macular edema due to central retinal vein occlusion that did not respond to treatment with bevacizumab or ranibizumab.  
medscape.com
over 3 years ago